Professional Documents
Culture Documents
Drug Monograph Sodamint
Drug Monograph Sodamint
Drug Monograph Sodamint
2.
Sodium bicarbonate
Sodium bicarbonate
500
Tablets
300 mg(3.57
mg
mEq/tab)
mmol)
50 ml.(44.6 mEq)
(Compliance)
4.
5.(Phar
: Alkalinizing agent,
: Alkalinizing agent,
macology)
Electrolyte supplement.
Electrolyte supplement.
: Sodium
: Sodium
bicarbonate
bicarbonate
Bicarbonate ion
Bicarbonate ion
PH
PH
6.
1.Metabolic acidosis
1.Metabolic acidosis
4.Urine Alkalinization
4.Urine Alkalinization
5.Antacid, Indigestion :
5.Antacid
7.
: Alkalosis,
: Alkalosis,
Hypernatremia, severe
edema, Hypocalemia
1. CSF
Intracranial hemorrhage
2.
1. CSF
Intracranial hemorrhage
2.
3.
2
hypernatremia
8.Pharmacokinetic
Volume of distribution
9.
-Metabolic acidosis : =
-Metabolic acidosis :
deficit(mEq/L) administer
: 1-3 mEq/kg/day
: 1-3 mEq/kg/day
: 20-36 mEq/day in
: 20-36 mEq/day in
divided doses,
divided doses,
18-20 mEq/L
18-20 mEq/L
: 2-3 mEq/kg/day
: 2-3 mEq/kg/day
: 0.5 2 mEq/kg/day in
: 0.5 2 mEq/kg/day in
-Urine Alkalinization :
-Urine Alkalinization :
: 1 10 mEq/kg/day
: 1 10 mEq/kg/day
4-6 ;
4-6 ;
pH
pH
: 48 mEq : 48 mEq
12-24 mEq 4 ;
12-24 mEq 4
pH
pH
200 mEq
200 mEq
60 100
60
mEq 60 -
100 mEq
-Indigestion :
60 -
Increased Effect :
amphetamines, ephedrine,
amphetamines, ephedrine,
pseudoephedrine, flecainide,
pseudoephedrine, flecainide,
urinary alkalinization.
urinary alkalinization.
Decreased Effect :
Decreased Effect :
alkalinization.
alkalinization.
11.
Hypernatemia, Hyperosmolarity,
Hypocalcemia, Hypokalemia,
edema
10.
Categoly : C
Categoly : C
Compatible
13.
(Clinical
Compatible
Efficacy)
14./
15./
0.5
Focus Pharmaceuticals Ltd
.
16.
Pharmaceuticals Ltd
17 Edition 2008-2009
17. .
18.
th